The stimulating adventure of KRN 7000. (Q33843406)

29 July 2017

1 reference

title

The stimulating adventure of KRN 7000. (English)

1 reference

29 July 2017

main subject

alpha-galactosylceramide

1 reference

ChEBI release 2020-05-28

4

Jean-Hugues Renault

1 reference

29 July 2017

author name string

Aline Banchet-Cadeddu

1

1 reference

29 July 2017

Eric Hénon

2

1 reference

29 July 2017

Manuel Dauchez

3

1 reference

29 July 2017

Fanny Monneaux

5

1 reference

29 July 2017

Arnaud Haudrechy

6

1 reference

29 July 2017

publication date

11 March 2011

1 reference

Organic and Biomolecular Chemistry

29 July 2017

published in

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

3080-3104

1 reference

Drug discovery from natural sources.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural products to drugs: natural product derived compounds in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Advanced preclinical and clinical trials of natural products and related compounds from marine sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Marine natural products and related compounds in clinical and advanced preclinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A concise synthesis of tetrahydroxy-LCB, alpha-galactosyl ceramide, and 1,4-dideoxy-1,4-imino-L-ribitol via D-allosamines as key building blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Efficient, one-pot syntheses of biologically active alpha-linked glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Immunotherapeutic potential for ceramide-based activators of iNKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Activation of NKT cells protects mice from tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Human NKT cells express granulysin and exhibit antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Effect of KRN7000 on induced graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Population pharmacokinetics of the novel anticancer agent KRN7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Structural and functional aspects of lipid binding by CD1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The crystal structure of human CD1d with and without alpha-galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Application of natural killer T cells in antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

NKT cells: potential targets for autoimmune disease therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Role of CD1d-restricted NKT cells in microbial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural killer T cells accelerate atherogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Toward an understanding of NKT cell biology: progress and paradoxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Historical review: Cytokines as therapeutics and targets of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Consideration of cytokines as therapeutics agents or targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Glycolipids for natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Glycolipids as immunostimulating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Glycolipid antigen processing for presentation by CD1d molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Lysosomal glycosphingolipid recognition by NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of diglycosylceramides and evaluation of their iNKT cell stimulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Interactions with aromatic rings in chemical and biological recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and in vitro evaluation of alpha-GalCer epimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and evaluation of amino-modified alpha-GalCer analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Total synthesis of an immunosuppressive glycolipid, (2S,3S,4R)-1-O- (alpha-d-galactosyl)-2- tetracosanoylamino-1,3,4-nonanetriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Equilibrium acidities in dimethyl sulfoxide solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Alpha-c-galactosylceramides: synthesis and immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

C-Galactosylceramide Diastereomers via Sharpless Asymmetric Epoxidation Chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of immunostimulatory alpha-C-galactosylceramide glycolipids via Sonogashira coupling, asymmetric epoxidation, and trichloroacetimidate-mediated epoxide opening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of thioglycoside-based UDP-sugar analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of S-linked glycopeptides in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of an S-linked glycopeptide analog derived from human Tamm-Horsfall glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Self glycolipids as T-cell autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Presentation of the same glycolipid by different CD1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Highly efficient and stereoselective synthesis of beta-glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

A newly discovered cholesteryl galactoside from Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis and In Vivo Evaluation of 4-Deoxy-4,4-difluoro-KRN7000

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of threitol ceramide and [14C]threitol ceramide, non-glycosidic analogues of the potent CD1d antigen α-galactosyl ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

Synthesis of α-galactosyl ceramide and the related glycolipids for evaluation of their activities on mouse splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0OB00975J

21 January 2018

Identifiers

DOI

10.1039/C0OB00975J

1 reference

29 July 2017

1 reference